Background Pneumonia is a common and potentially serious illness. Corticosteroids have
been suggested for the treatment of different types of infection, however their role in the …

Pneumonia is a leading cause of hospitalization among both adults and children in the
United States, accounting for more than 800,000 hospitalizations and more than 400,000 …

Rationale: There are no risk stratification tools for morbidity and mortality in bronchiectasis.
Identifying patients at risk of exacerbations, hospital admissions, and mortality is vital for …

Rationale: There is a need to identify clinically meaningful predictors of mortality following
hospitalized COPD exacerbation. Objectives: The aim of this study was to systematically …

Abstract Background. The 2005 American Thoracic Society/Infectious Diseases Society of
America guidelines introduced a concept of healthcare-associated pneumonia (HCAP) to …

Introduction The increase and persistence of inflammation in community-acquired
pneumonia (CAP) patients can lead to higher mortality. Biomarkers capable of measuring …

Introduction The COVID-19 pandemic is ongoing, yet, due to the lack of a COVID-19-specific
tool, clinicians must use pre-existing illness severity scores for initial prognostication …

Objectives To review literature reporting adverse events and physiological instability in order
to develop frameworks that describe and define clinical deterioration in hospitalised …

Objectives Serum levels of potassium (K+) appear to be significantly lower in severe cases
of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the clinical …

Introduction Severity assessment and site-of-care decisions for patients with community-
acquired pneumonia (CAP) are pivotal for patients' safety and adequate allocation of …